Pharmacists in Camden, Arkansas


12 Pharmacists found in Camden
female pharmacist

Angela Bryant Jeffus


Pharmacist
1286 Highway 278 Byp, Camden, AR 71701
870-836-8131     870-836-9314

female pharmacist

Barbara Jeans, PHARMD


Pharmacist
424 California Ave Sw, Camden, AR 71701
870-836-4157     870-836-0962

female pharmacist

Elizabeth L Tuberville


Pharmacist
1005 W Washington St, Camden, AR 71701
870-836-9303    



male pharmacist

James Elliott Jones Jr., BSPHARM


Pharmacist
745 Frazier Ave, Camden, AR 71701
281-300-8259     870-836-5957

female pharmacist

Jamie Blaine Brown, PHARM D


Pharmacist
1345 Hwy 4 Spur Sw, Camden, AR 71701
870-836-3324     870-836-3715

female pharmacist

Janet R Fisher, RPH


Pharmacist
424 California Ave Sw, Camden, AR 71701
870-836-4157    

female pharmacist

Katy Denise Bostic, PHARM D


Pharmacist
1286 Highway 278 Byp, Camden, AR 71701
870-836-8132     870-836-9314

female pharmacist

Dr. Kelsey Lauren Maloch


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
950 California Ave Sw, Camden, AR 71701
870-836-8025    

male pharmacist

Kofi Asafo Boakye, PHARM D


Pharmacist
424 California Ave Sw, Camden, AR 71701
870-836-4157    

male pharmacist

Dr. Kyle Hively, PHARMD


Pharmacist
638 California Ave Sw, Camden, AR 71701
870-836-1296     870-836-1041

female pharmacist

Teresa Mccann, PHARMD


Pharmacist
Brookshire's Pharmacy #85, 1345 Hwy 4 Spur Sw, Camden, AR 71701
870-836-3324     866-572-0138

male pharmacist

William B Morrison Jr., P.D.


Pharmacist
1286 Highway 278 Byp, Camden, AR 71701
870-836-8132     870-836-9314


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.